The Potential of Glucagon-like Peptide-1 Receptor Agonists in Addictive Disorders
Medical Research Archives · 2025 · 14 (2)
DOI: 10.18103/mra.v14i2.7249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Archives, 2025. Verfasst von Sigrid Breit. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Addictive disorders are often difficult to treat and show high relapse rates. Particularly, alcohol use disorder presents a major treatment challenge leading to severe physical and mental health impacts. So far, pharmacological treatment options are limited. Agonists of the glucagon-like peptide-1 receptor (GLP-1RAs) are anti-hyperglycemic and weight-reducing drugs that have anti-inflammatory properties and can modulate brain reward pathways. Mounting evidence suggests that GLP-1RAs may have the potential to treat addictive disorders. The aim of this review is to give an insight into the neurobiological mechanisms by which GLP-1RAs influence addiction and to evaluate their effectiveness across different substances and behavioral addictions.
Zitieren
APA
Breit, S. (2025). The Potential of Glucagon-like Peptide-1 Receptor Agonists in Addictive Disorders. Medical Research Archives, 14(2). https://doi.org/10.18103/mra.v14i2.7249
Vancouver
Breit S. The Potential of Glucagon-like Peptide-1 Receptor Agonists in Addictive Disorders. Medical Research Archives. 2025;14(2). doi:10.18103/mra.v14i2.7249
BibTeX
@article{Breit2025,
author = {Breit, Sigrid},
title = {The Potential of Glucagon-like Peptide-1 Receptor Agonists in Addictive Disorders},
journal = {Medical Research Archives},
year = {2025},
volume = {14},
number = {2},
doi = {10.18103/mra.v14i2.7249}
}
EUVIMED